Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
methylphenidate (ritalin) (1 trial)
pimavanserin (nuplazid) (1 trial)
quetiapine (seroquel) (1 trial)
spironolactone (aldactone) (1 trial)
cad106 (1 trial)
e2814 (1 trial)
gantenerumab (3 trials)
glucose (1 trial)
LECANEMAB (Leqembi) (1 trial)
malic acid (1 trial)
omega-3 fatty acids (Omacor) (1 trial)
resveratrol (1 trial)
solanezumab (2 trials)
Umibecestat (1 trial)
bosutinib (bosulif) (1 trial)
donepezil (aricept) (1 trial)
enduramide (1 trial)
estrogen (1 trial)
formoterol (foradil) (1 trial)
insulin detemir (Levemir) (1 trial)
insulin human (humulin) (2 trials)
lidocaine (xylocaine) (1 trial)
mk 6240 (1 trial)
mw189 (1 trial)
nicotinamide (1 trial)
pepinemab (1 trial)
prilocaine (citanest) (1 trial)
progesterone (progestasert) (1 trial)
sargramostim (leukine) (1 trial)
semaglutide (Ozempic) (1 trial)
sodium chloride (1 trial)
sodium phenylbutyrate (buphenyl) (1 trial)
sucrose (1 trial)
tt301 (1 trial)
ursodeoxycholic acid (1 trial)
valaciclovir (Valtrex) (1 trial)
123i impy (1 trial)
brexanolone (Zulresso) (1 trial)
cisplatin (platinol) (1 trial)
contraloid (1 trial)
cpg 1018 (1 trial)
cyclophosphamide (cytoxan) (1 trial)
doxorubicin (Doxil) (1 trial)
emtricitabine (emtriva) (1 trial)
flortaucipir (Tauvid) (1 trial)
ibc-ab002 (1 trial)
npt088 (1 trial)
verdiperstat (1 trial)
xpro1595 (1 trial)
creatine (1 trial)
Alzheimer Disease (Phase 4)
Cognition Disorders (Phase 1)
Cognitive Dysfunction (Phase 4)
Dementia (Phase 4)
Diabetes Mellitus (Phase 4)
Lewy Body Disease (Phase 2)
Trials (35 total)
Trial APIs (50 total)